Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.63B | 12.75B | 13.12B | 12.65B | 11.75B | 13.77B |
Gross Profit | 4.57B | 4.54B | 4.28B | 3.81B | 3.82B | 4.73B |
EBITDA | 2.34B | 2.33B | 1.76B | 1.58B | 2.12B | 2.36B |
Net Income | 1.38B | 1.34B | 951.00M | 960.00M | 1.49B | 1.25B |
Balance Sheet | ||||||
Total Assets | 15.47B | 15.63B | 15.62B | 18.50B | 18.18B | 18.00B |
Cash, Cash Equivalents and Short-Term Investments | 330.00M | 694.00M | 274.00M | 299.00M | 286.00M | 435.00M |
Total Debt | 6.22B | 6.34B | 6.53B | 7.16B | 7.73B | 8.11B |
Total Liabilities | 11.45B | 11.75B | 12.25B | 14.12B | 13.96B | 14.36B |
Stockholders Equity | 3.92B | 3.77B | 3.17B | 3.94B | 3.72B | 3.11B |
Cash Flow | ||||||
Free Cash Flow | 863.00M | 1.13B | 968.00M | 1.16B | 1.15B | 1.48B |
Operating Cash Flow | 1.51B | 1.76B | 1.65B | 1.65B | 1.70B | 1.99B |
Investing Cash Flow | -569.00M | -750.00M | -562.00M | -448.00M | -528.00M | -585.00M |
Financing Cash Flow | -862.00M | -607.00M | -1.11B | -1.08B | -1.31B | -1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $33.94B | 21.22 | 37.48% | 3.27% | -5.91% | -19.78% | |
74 Outperform | $19.75B | 25.65 | 14.19% | 2.44% | 0.89% | 4.85% | |
72 Outperform | $87.12B | 25.43 | 13.27% | 2.79% | 0.90% | -14.60% | |
68 Neutral | $30.45B | 11.66 | 5.36% | 6.22% | -4.25% | -4.04% | |
65 Neutral | $26.82B | 14.80 | -4.06% | 3.24% | 1.02% | 2.12% | |
64 Neutral | $27.01B | 19.62 | 39.05% | 2.93% | -12.00% | 49.20% | |
63 Neutral | $27.58B | 12.36 | 24.57% | 4.74% | -1.87% | -5.16% |
On June 25, 2025, Kellanova and Mars, Incorporated announced that the U.S. Federal Trade Commission had completed its antitrust review of Mars’ pending acquisition of Kellanova without any conditions. This marks a significant milestone towards the merger, which is expected to close by the end of 2025, pending European Commission approval. The merger aims to combine the complementary strengths of both companies, enhancing their global snacking business and better meeting consumer needs.
The most recent analyst rating on (K) stock is a Hold with a $61.00 price target. To see the full list of analyst forecasts on Kellanova stock, see the K Stock Forecast page.
Kellanova, a Delaware corporation, has entered into a Merger Agreement with Acquiror 10VB8, LLC and Mars, Incorporated, where Kellanova will become a wholly-owned subsidiary of Acquiror. The European Commission has initiated a Phase II investigation into the merger, which is expected to close towards the end of 2025, pending regulatory approvals.
The most recent analyst rating on (K) stock is a Hold with a $61.00 price target. To see the full list of analyst forecasts on Kellanova stock, see the K Stock Forecast page.
On May 6, 2025, Kellanova announced the resignation of Amit Banati, the Vice Chairman and Chief Financial Officer, effective May 9, 2025, as he pursues another opportunity. The company appointed John Renwick as the acting Senior Vice President and Chief Financial Officer, effective May 9, 2025, who has been with the company since 2000 and has extensive experience in finance and investor relations.